炎症性溃疡性结肠炎区域与MRGPRX2介导的肥大细胞脱颗粒及细胞激活模块相关,定义新治疗靶点
该研究探讨肥大细胞在人类溃疡性结肠炎(UC)中的作用。通过结肠组织转录组测序、固有层细胞MRGPRX2激活研究及单细胞RNA测序,并结合Ashkenazi犹太UC病例对照队列的GPCR单核苷酸多态性关联分析,发现炎症UC区域肥大细胞特异性介质和肾上腺髓质素上调,MRGPRX2刺激诱导羧肽酶分泌;MRGPRX2变异Asn62Ser与UC最相关且被预测改变抑制蛋白招募,UC保护性丝氨酸等位基因增强β-抑制蛋白招募、降低IP-1并增加磷酸化ERK;单细胞测序显示肾上腺髓质素由活化成纤维细胞和上皮细胞表达,干扰素γ是肥大细胞基因表达的关键上游调节因子。结论指出炎症UC区域以MRGPRX2介导的肥大细胞激活为特征,UC保护性遗传变异可减弱该激活,定义了UC激活的细胞模块和新治疗靶点。
要点
- 炎症UC区域肥大细胞特异性介质和MRGPRX2激动剂前体肾上腺髓质素上调。
- MRGPRX2变异Asn62Ser与UC最相关,保护性丝氨酸等位基因增强β-抑制蛋白招募。
- 干扰素γ是肥大细胞基因表达的关键上游调节因子。
核心结论
- 炎症UC区域以MRGPRX2介导的肥大细胞激活为特征,UC保护性遗传变异可减弱该激活,定义了UC激活的细胞模块和新治疗靶点。
研究设计与样本
- 收集UC患者结肠组织进行bulk RNA测序,分离固有层细胞进行MRGPRX2激活研究和单细胞RNA测序。
- 在Ashkenazi犹太UC病例对照队列中进行所有改变蛋白质的G蛋白偶联受体单核苷酸多态性遗传关联分析。
- 将MRGPRX2变异转染至中国仓鼠卵巢(CHO)和人肥大细胞(HMC)1.1细胞,检测基因型依赖的β-抑制蛋白招募、IP-1积累和磷酸化细胞外信号调节激酶效应。
主要发现
- 与未炎症UC相比,炎症UC中肥大细胞特异性介质和肾上腺髓质素(PAMP-12的蛋白水解前体,一种MRGPRX2激动剂)上调。
- MRGPRX2刺激诱导炎症UC来源的羧肽酶分泌。
- 在所有改变蛋白质的GPCR等位基因中,MRGPRX2独特变异Asn62Ser与UC最相关,并被生物信息学预测改变抑制蛋白招募。
- 验证显示UC保护性丝氨酸等位基因在MRGPRX2激动剂存在下增强β-抑制蛋白招募、降低IP-1并增加磷酸化细胞外信号调节激酶。
- 单细胞RNA测序定义肾上腺髓质素由活化成纤维细胞和上皮细胞表达,干扰素γ是肥大细胞基因表达的关键上游调节因子。
临床怎么用
- MRGPRX2介导的肥大细胞激活可作为UC的新治疗靶点。
- MRGPRX2变异Asn62Ser可能作为UC遗传易感性的生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Recent literature has implicated a key role for mast cells in murine models of colonic inflammation, but their role in human ulcerative colitis (UC) is not well established. A major advance has been the identification of mrgprb2 (human orthologue, MRGPX2) as mediating IgE-independent mast cell activation. We sought to define mechanisms of mast cell activation and MRGPRX2 in human UC. METHODS: Colon tissues were collected from patients with UC for bulk RNA sequencing and lamina propria cells were isolated for MRGPRX2 activation studies and single-cell RNA sequencing. Genetic association of all protein-altering G-protein coupled receptor single-nucleotide polymorphism was performed in an Ashkenazi Jewish UC case-control cohort. Variants of MRGPRX2 were transfected into Chinese hamster ovary (CHO) and human mast cell (HMC) 1.1 cells to detect genotype-dependent effects on β-arrestin recruitment, IP-1 accumulation, and phosphorylated extracellular signal-regulated kinase. RESULTS: Mast cell-specific mediators and adrenomedullin (proteolytic precursor of PAMP-12, an MRGPRX2 agonist) are up-regulated in inflamed compared to uninflamed UC. MRGPRX2 stimulation induces carboxypeptidase secretion from inflamed UC. Of all protein-altering GPCR alleles, a unique variant of MRGPRX2, Asn62Ser, was most associated with and was bioinformatically predicted to alter arrestin recruitment. We validated that the UC protective serine allele enhances β-arrestin recruitment, decreases IP-1, and increases phosphorylated extracellular signal-regulated kinase with MRGPRX2 agonists. Single-cell RNA sequencing defines that adrenomedullin is expressed by activated fibroblasts and epithelial cells and that interferon gamma is a key upstream regulator of mast cell gene expression. CONCLUSION: Inflamed UC regions are distinguished by MRGPRX2-mediated activation of mast cells, with decreased activation observed with a UC-protective genetic variant. These results define cell modules of UC activation and a new therapeutic target.
引用
- Chen E, Chuang LS, Giri M, et al. Inflamed Ulcerative Colitis Regions Associated With MRGPRX2-Mediated Mast Cell Degranulation and Cell Activation Modules, Defining a New Therapeutic Target. Gastroenterology. 2021. PMID: 33421512. doi:10.1053/j.gastro.2020.12.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。